Tweak receptor agonists as anti-angiogenic agents

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/395 (2006.01) A61K 38/17 (2006.01) A61P 35/00 (2006.01) C07K 16/28 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2422095

The present invention relates to methods of modulating angiogenesis and inhibiting tumor progression by using TWEAK receptor (Fn14) agonists. In particular, methods for inhibiting angiogenesis are disclosed.

La présente invention porte sur des procédés de modulation de l'angiogenèse et d'inhibition de la progression tumorale qui utilisent des agonistes du récepteur TWEAK (Fn14). L'invention porte notamment sur des procédés d'inhibition de l'angiogenèse.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Tweak receptor agonists as anti-angiogenic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tweak receptor agonists as anti-angiogenic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tweak receptor agonists as anti-angiogenic agents will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1963100

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.